News | June 25, 2015

Delaware Enacts Breast Density Inform Law

Becomes the 23rd state to enact this legislation

Dense breast tissue

Governor Jack Markell has just signed Delaware's Breast Density Notification Act (SB 37) into law. Delaware becomes the 23rd state to enact such legislation. The law becomes effective 180 days after the Governor's signature.

Other states that have introduced bills in 2015 include Georgia, Iowa, Kentucky, Mississippi, South Carolina and Washington.

On the federal regulatory level, the Food and Drug Administration (FDA) anticipates issuing a Breast Density Reporting amendment to the Mammography Quality Standards Act (MQSA) as a "Notice of Proposed Rulemaking" in 2015. On the federal legislative front, the Breast Density and Mammography Reporting Act of 2015 has been introduced in both the House (HR 716) and Senate (S 370). 

"We applaud the hard work of Delaware legislators in advancing this bill into law. The good news is that 65 percent of American women now live in states with some level of mandatory breast density notification. The bad news is that 35 percent do not. We look forward to progress on the federal level which could create a national standard for the remaining 35 percent of women," says DENSE advocacy group cofounder JoAnn Pushkin.

For further explanation about federal efforts and for state-by-state legislative analysis, visit the "Legislation" tab at the new educational website DenseBreast-info.org.

States with breast density inform laws in order of enactment include Connecticut, Texas, Virginia, New York, California, Hawaii, Maryland, Tennessee, Alabama, Nevada, Oregon, North Carolina, Pennsylvania, New Jersey, Arizona, Minnesota, Rhode Island, Massachusetts, Missouri, Ohio, Michigan, North Dakota and Delaware.

For more information: http://legis.delaware.gov/LIS/lis148.nsf/EngrossmentsforLookup/SB+37/$file/Engross.html?open

Related Content

Biop Medical Launches Cervical Cancer Diagnosis Technology at MEDICA 2017

Biop Medical cervical cancer detection system

Technology | Women's Health | November 13, 2017
November 13, 2017 — Biop Medical announced it will present its point-of-care...
Kansas City Radiology Center Employs iCAD PowerLook Tomo Detection for DBT
News | Computer-Aided Detection Software | November 10, 2017
November 10, 2017 — Imaging for Women, a leading radiology center in Kansas City, Mo., announced it is now using iCAD
Kubtec Brings Image Analytics Capabilities to Tomosynthesis Specimen Imaging Systems
News | Mammography | November 10, 2017
Kubtec announced it will be showcasing new image analytics capabilities on its advanced tomosynthesis specimen imaging...
Siemens Healthineers Introduces Share360 Tailored Service Portfolio
News | Imaging | November 10, 2017
November 10, 2017 — To address the specific needs of...
Fujifilm Highlights Women's Health and Pediatrics at RSNA 2017
News | Information Technology | November 08, 2017
November 8, 2017 — Fujifilm Healthcare will showcase a variety of imaging and information technology solutions at the
CureMetrix Expands Medical Advisory Board
News | Computer-Aided Detection Software | November 08, 2017
November 8, 2017 — CureMetrix, a company developing...
ICPME Makes EQUIP Mammography Inspection CME/CE Webinar Available Online
News | Mammography | November 08, 2017
November 8, 2017 — In conjunction with Brea...
Study Suggests Breast Cancer Patients Forego Post-Surgery Treatment Due to Mistrust
News | Radiation Therapy | November 06, 2017
November 6, 2017 — Nearly one-third of women with...
Study shows tissue marker reduces radiation target volumes, produces many other advantages

These CT images show placement of a 3-D fixed array implanted fiducial (3-D marker) at the time of oncoplastic tumor resection. The original LCTV (LCTVo) was retrospectively re-contoured by the radiation oncologist (LCTVro) and breast surgeon (LCTVbs). Thereafter, both re-contours were combined to create the collaborative LCTV (LCTVc), which required agreement of both the radiation oncologist and breast surgeon. Volume differences between the original LCTV (LCTVo) and the collaborative LCTVc were then evaluated, and demonstrated a mean and median reduction in LCTV.

Feature | Tumor Tracking Systems | November 06, 2017 | By William Hall, M.D.
Radiation planning for breast cancer relies on accurate delineation of the post-lumpectomy target volume as identified...
Blood Test Rules Out Breast Cancer Regardless of Density
News | Oncology Diagnostics | November 03, 2017
November 3, 2017 — A new study published in ...
Overlay Init